Quantum computing stocks face tougher investor scrutiny as QUBT and QNT show 77 percent upside on analyst targets, while IONQ and QBTS carry Sell ratings.
Zacks Equity Research analysts said the sector's shift toward commercialization is separating winners from laggards, with investors demanding evidence that bookings and partnerships translate into scalable revenue.
QUBT's Q2 2026 revenue jumped to $5.6 million from $61,000 a year earlier, with contract backlog reaching approximately $42.5 million. QNT's Q2 revenue rose 279 percent year over year, and the company raised its 2026 revenue outlook to $28-$32 million with year-to-date bookings of $81 million. By contrast, IONQ delivered 287 percent YoY revenue growth but carries a Zacks Rank #4 (Sell), while QBTS saw first-half bookings surge 1,120 percent but Q2 revenue was only $3.1 million.
The divergence reflects a sector-wide repricing as persistent inflation, elevated yields and a cooling labor market raise the hurdle for speculative tech stocks. The 30-year Treasury yield sits around 5.25 percent with US debt surpassing $40 trillion, pressuring long-duration growth names.
The macro backdrop has turned less forgiving for high-risk growth stocks. The Fed held the federal funds target range at 3.5 percent to 3.75 percent at its July 29 meeting, while July CPI rose 3.4 percent year over year and core CPI was up 2.5 percent. June PCE rose 3.7 percent year over year, and July PPI climbed 4.7 percent. July nonfarm payrolls declined 23,000 with unemployment at 4.1 percent.
Commercialization Becomes the Differentiator
Washington continues to back quantum development. A June 22 White House executive order called for a national effort to build a powerful quantum computer, and the Department of Energy launched its Quantum Genesis initiative. But government support does not eliminate execution risk, Zacks analysts said.
QUBT is building exposure across quantum photonics, semiconductors and quantum optimization rather than relying on a single hardware pathway. The company completed its NHanced Semiconductors acquisition and delivered its Dirac-3 quantum optimization system to a global consulting firm. Six analysts set an average price target of $18.33, implying 125.2 percent upside from the last close of $8.14.
QNT offers an enterprise-focused full-stack model spanning hardware, software and applications. Its Helios system demonstrated near-five-nines logical fidelity, and the planned integration with Oracle Cloud Infrastructure provides another avenue for enterprise adoption. With more than $2 billion in cash after its IPO, QNT has substantial resources to fund development. Twelve analysts set an average price target of $97.17, implying 77 percent upside from $54.90.
IONQ raised its 2026 revenue outlook to $280-$290 million after Q2 revenue grew 287 percent year over year, but the company continues heavy investment following its $1.8 billion SkyWater acquisition. While Zacks assigns IONQ a Rank #4 (Sell), TipRanks data shows a Strong Buy consensus with an average price target of $69.44, implying about 57 percent upside. QBTS expanded its AT&T agreement for quantum annealing in telecom network optimization, yet its Q2 revenue of $3.1 million remains far below its bookings trajectory. TipRanks data shows QBTS carries a Strong Buy consensus with an average price target of $35.79, implying 78.5 percent upside from $20.03.
The sector's key bottleneck is turning bookings, pilots and technical advances into recurring revenue at scale. Investors will watch IONQ's Investor Day on September 8 for updated guidance on margins and commercialization timelines.
This article is for informational purposes only and does not constitute investment advice.